Renwick et al. [13] did not compare the breast cancer risks associated with protein-truncating versus missense mutations in ATM. Bernstein et al. [10] had previously identified seven carriers of this mutation in the three population-based sites of the BCFR; however, no family members were genotyped in this study. The gene discussed is ATM; the disease is breast cancer.